EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications

Neha Raut iD, Anis A Chaudhary iD, Harshad Patil, Supriya Shidhaye, Ruchi Khobragade, Milind Umekar iD, Mohamed A M Ali iD, Rashmi Trivedi

Pathogens · 10.04.2026 · 15 (4) · 414

DOI: 10.3390/pathogens15040414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 10.04.2026. Verfasst von Neha Raut und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, Maharashtra, India. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Bacterial Agents, Drug Resistance, Bacterial, Drug Utilization. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imam Mohammad ibn Saud Islamic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Antimicrobial resistance (AMR) is a critical global public health challenge driven by inappropriate and excessive antimicrobial use (AMU) across human, animal, and environmental sectors.

Method

This narrative review synthesizes recent evidence on antimicrobial utilization and resistance patterns. A structured search of PubMed, Scopus, and Web of Science was conducted for studies published between 2015 and 2025. Eligible sources included surveillance reports, registry-based analyses, and clinical studies. Data were qualitatively analyzed to identify key trends and regional variations.

Result

Marked geographical variation in AMR was observed. Carbapenem resistance in Escherichia coli remains low globally (2–3%) but is higher in Southeast Asia (17–18%) and India (~40%). Klebsiella pneumoniae shows consistently high resistance (>40% globally; ~54% in India), while Pseudomonas aeruginosa exhibits stable resistance levels (35–45%). Resistance prevalence increases from primary to tertiary care settings, reflecting greater antimicrobial exposure. Vulnerable populations—including pediatric, elderly, pregnant, and immunocompromised patients—face higher risks of antimicrobial exposure and adverse outcomes, including nephrotoxicity, hepatotoxicity, and microbiome disruption. WHO AWaRe data indicate a global shift toward increased use of Watch-category antibiotics. Stewardship interventions, such as audit and feedback, prescribing restrictions, rapid diagnostics, and decision support systems, effectively reduce inappropriate AMU.

Conclusions

Integrated, data-driven antimicrobial stewardship and robust surveillance systems are essential to mitigate the global burden of AMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipAnti-Bacterial AgentsDrug Resistance, BacterialDrug UtilizationHumansGlobal HealthAnimalsDelivery of Health Care

Stichwörter der Autor:innen

One Healthantimicrobial resistanceantimicrobial stewardshipantimicrobial usedrug utilizationhealthcare settingsmonitoringsafetyvulnerable populations

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, Maharashtra, India.
  • Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
  • Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, Maharashtra, India.

ORCID-Profile: Neha Raut, Anis A Chaudhary, Milind Umekar, Mohamed A M Ali

Förderung

  • Imam Mohammad ibn Saud Islamic University

Zitieren

APA

Raut, N., Chaudhary, A. A., Patil, H., Shidhaye, S., Khobragade, R., Umekar, M., Ali, M. A. M., & Trivedi, R. (2026). Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications. Pathogens, 15(4), 414. https://doi.org/10.3390/pathogens15040414

Vancouver

Raut N, Chaudhary AA, Patil H, Shidhaye S, Khobragade R, Umekar M, et al. Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications. Pathogens. 2026;15(4):414. doi:10.3390/pathogens15040414

BibTeX
@article{Raut2026,
  author = {Raut, Neha and Chaudhary, Anis A and Patil, Harshad and Shidhaye, Supriya and Khobragade, Ruchi and Umekar, Milind and Ali, Mohamed A M and Trivedi, Rashmi},
  title = {Antimicrobial Consumption and Resistance Dynamics Across Healthcare Level: Global Evidence and Stewardship Implications},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {414},
  doi = {10.3390/pathogens15040414}
}
Kostenlos starten →